NRC Health

Hello and welcome to today's National Research Corporation second quarter 2023 earnings call. My name is Bailey and I'll be your moderator for today. All lines will be muted during the presentation portion of the call with an opportunity for questions and answers at the end. If you would like to ask a question, please press star followed by one on your telephone keypad. I'd now like to pass the conference over to Kevin Karras, Chief Financial Officer. Please go ahead.

Thank you, Bailey. and welcome everyone to National Research Corporation's 2023 Second Quarter Earnings Call. My name is Kevin Karas, the company's CFO, and joining me on the call today is Linda Stacey, our Vice President of Finance. Before we continue, I'd like to ask Linda to review conditions related to any forward-looking statements that may be made as part of today's call. Linda?

Thank you, Kevin. This conference call includes forward-looking statements related to the company that involve risks and uncertainties that could cause actual results or outcomes to differ materially from those currently anticipated. These forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. For further information about the facts that could affect the company's future results, please see the company's filings with the Securities and Exchange Commission. With that, I'll turn it back to you, Kevin.